Rochester N.Y.-It is a done deal.

 Valeant Pharmaceuticals of Canada announcing today it has completed its acquisition of Bausch + Lomb.

That news comes just days after Valeant informed B+L employees of plans to move the Bausch headquarters out of Rochester and into New Jersey.

The $8.7 billion acquisition was announced this spring.